Non-Current Assets
PP&E (Net)
Pfizer PP&E (Net) increased by 2.3% to $19.32B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $18.39B to $19.32B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 6.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase indicates investment in future capacity or infrastructure, while a decrease suggests asset aging or a shift toward an asset-light model.
Detailed definition
The book value of long-term physical assets such as manufacturing facilities, data centers, and retail stores, net of ac...
Peer comparison
Varies significantly based on whether a company owns its manufacturing plants or outsources production to third-party partners.
Metric ID:
property_plant_equipment_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.22B | $14.44B | $14.88B | $15.11B | $15.24B | $15.44B | $16.27B | $17.05B | $17.49B | $17.86B | $18.94B | $18.80B | $18.96B | $18.54B | $18.39B | $18.35B | $18.78B | $18.88B | $19.32B |
| QoQ Change | — | +1.5% | +3.1% | +1.5% | +0.9% | +1.3% | +5.4% | +4.8% | +2.6% | +2.1% | +6.0% | -0.7% | +0.8% | -2.2% | -0.8% | -0.3% | +2.3% | +0.6% | +2.3% |
| YoY Change | — | — | — | — | +7.2% | +7.0% | +9.4% | +12.9% | +14.7% | +15.7% | +16.4% | +10.3% | +8.4% | +3.8% | -2.9% | -2.4% | -1.0% | +1.8% | +5.0% |
Range$14.22B – $19.32B
CAGR+7.0%
Avg YoY Growth+7.1%
Median YoY Growth+7.2%
Current Streak3 quarters growth
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Pfizer's pp&e (net)?
- Pfizer (PFE) reported pp&e (net) of $19.32B in Q4 2025.
- How has Pfizer's pp&e (net) changed year-over-year?
- Pfizer's pp&e (net) increased by 5.0% year-over-year, from $18.39B to $19.32B.
- What is the long-term trend for Pfizer's pp&e (net)?
- Over 5 years (2020 to 2025), Pfizer's pp&e (net) has grown at a 6.8% compound annual growth rate (CAGR), from $13.90B to $19.32B.
- What does pp&e (net) mean?
- The value of the company's physical buildings, machinery, and equipment after accounting for wear and tear.